Business
BioSpectrum Asia
How technology and AI are democratising healthcare
As Artificial Intelligence AI) continues to shape the way we work and live, we must ensure that we are tapping into its full potential when it comes to the healthcare space. By leveraging its unique capabilities to address the accessibility barriers that we see in our healthcare centres in the APAC region and equip policymakers and industry leaders with the knowledge, tools and information to change and democratise our healthcare systems.
5 min |
August 2024
BioSpectrum Asia
"We're seeing Al-powered diagnostic tools enhancing accuracy and efficiency, across multiple sectors"
In July 2024, Advanced MedTech Holdings (AMTH) appointed Wong Yau Chung as its new Group Chief Executive Officer, succeeding his role as Group Chief Operating Officer. With a core focus in urology devices and contract manufacturing services, the company serves millions of patients and physicians across 100 countries worldwide. Wong Yau Chung interacts with BioSpectrum Asia and shares his vision for Advanced MedTech Holdings' future and insights on key trends shaping the medtech industry.
4 min |
August 2024
BioSpectrum Asia
Addressing Root Causes of Brain Disorders with Innovative Therapeutics
Neuroscience is a complex market encompassing a range of neurological conditions.
10+ min |
August 2024
BioSpectrum Asia
PAHO and World Bank launch PROTECT project to strengthen pandemic response in South America
The Pan American Health Organization (PAHO) and the World Bank have launched the PROTECT Project, an initiative to improve pandemic response in seven South American countries.
1 min |
August 2024
BioSpectrum Asia
WHO prequalifies first self-test for hepatitis C virus
The World Health Organization (WHO) has prequalified the first hepatitis C virus (HCV) self-test which can provide a critical support in expanding access to testing and diagnosis, accelerating global efforts to eliminate hepatitis C.
1 min |
August 2024
BioSpectrum Asia
Psylo partners with University of Sydney to deliver psychedelic treatments in Australia
The University of Sydney's Brain and Mind Centre has partnered with Psylo, a global biotechnology startup and pioneer in nonhallucinogenic psychedelic drugs, to develop innovative treatments for psychiatric and neurological disorders using advanced artificial intelligence technologies. Researchers at the University of Sydney's School of Psychology have developed machinelearning-guided behavioural analysis technology, which utilises high frame-rate cameras and sophisticated dataparsing techniques to predict the behavioural profiles and potential therapeutic properties of new drugs.
1 min |
August 2024
BioSpectrum Asia
Hyundai Bioscience develops multi-treatment drug to treat mosquito-borne viral infections
Korea-based Hyundai Bioscience, which is preparing for a dengue fever basket clinical trial in Brazil, has successfully developed a multi-treatment drug for mosquito-borne viral infections, including dengue fever, using niclosamide as the main ingredient.
1 min |
August 2024
BioSpectrum Asia
GSK, MVV launch malaria medicine in Brazil and Thailand
GSK plc and Medicines for Malaria Venture (MMV) اله Aq re m have announced that the first single-dose medicine for the prevention of relapse of Plasmodium vivax (P. vivax) malaria - tafenoquine, co-administered with chloroquine for radical cure, has now been launched in both Thailand and Brazil, in support of malaria elimination efforts.
1 min |
August 2024
BioSpectrum Asia
Taiwan's Bora Pharma buys Emergent BioSolutions' manufacturing site for $30M
The US-based Emergent BioSolutions Inc. has entered into a definitive agreement to sell its drug product facility in Baltimore-Camden to an affiliate of Taiwan's Bora Pharmaceuticals Co., a leading international pharmaceutical services company, for a total value of approximately $30 million.
1 min |
August 2024
BioSpectrum Asia
Merck expands production capabilities for cell culture media with €6.6M investment in China
Merck has announced the start of commercial production of its first Good Manufacturing Practices (GMP) compliant manufacturing line for cell culture media (CCM) in China.
1 min |
August 2024
BioSpectrum Asia
Bangkok Hospital invests 200 M baht to establish robotic surgery centre
Bangkok Hospital, a leading healthcare provider in Thailand, has invested over 200 million baht to establish a cutting-edge robotic surgery centre.
1 min |
August 2024
BioSpectrum Asia
Asia's first health research related preclinical network facility opens in Faridabad
Dr Jitendra Singh, Minister of State (Independent Charge) for Science and Technology and Earth Sciences, Government of India, has inaugurated Asia's first health research-related 'Pre-clinical Network Facility' under the Coalition of Epidemic Preparedness Innovations (CEPI) at the Regional Centre of Biotechnology under the aegis of the Translational Health Science & Technology Institute (THSTI), Faridabad.
1 min |
August 2024
BioSpectrum Asia
Korea announces launch of mental health policy innovation committee
The South Korean government recently convened the inaugural meeting of the Mental Health Policy Innovation Committee at the National Center for Mental Health.
1 min |
August 2024
BioSpectrum Asia
Australia delivers first aged care digital plan
The Australian government has released its first Aged Care Data and Digital Strategy.
1 min |
August 2024
BioSpectrum Asia
Sartorius opens new CoE for bioanalytics in US
Germany-headquartered life science group Sartorius has opened its new Center of Excellence (CoE) for bioanalytics in Ann Arbor, Michigan, US two years after breaking ground in the Tech Loop at Research Park.
1 min |
BioSpectrum Asia July 2024
BioSpectrum Asia
Singapore-Japan team finds common virus that triggers growth of nasopharyngeal cancer
Scientists from Nanyang Technological University, Singapore (NTU Singapore) and Chiba University in Japan have shown how the Epstein-Barr virus (EBV) alters specific genes, making nasopharyngeal cancer tumours (NPC) grow faster.
1 min |
BioSpectrum Asia July 2024
BioSpectrum Asia
Prof. Liu Xiaogang wins prestigious Royal Society of Chemistry Prize
Professor Liu Xiaogang from the Department of Chemistry, National University of Singapore (NUS) has been named winner of the Royal Society of Chemistry’s Centenary Prize in recognition of brilliance in research and innovation.
1 min |
BioSpectrum Asia July 2024
BioSpectrum Asia
New blood test by Australian scientists tracks brain recovery after concussion
A blood test can accurately detect the ongoing effects of sport-related concussion and help determine when it’s safe to return to the field, Australia's Monash University-led research has found.
1 min |
BioSpectrum Asia July 2024
BioSpectrum Asia
Australian Digital Health Agency appoints Dr Amandeep Hansra as new Chief Clinical Adviser (Medicine)
The Australian Digital Health Agency, the Australian Government’s statutory agency responsible for My Health Record, Australia's digital prescriptions and health referral system, and other e-health programmes under the national digital health strategy, has announced the appointment of Dr Amandeep Hansra as its new Chief Clinical Adviser (Medicine).
1 min |
BioSpectrum Asia July 2024
BioSpectrum Asia
Macro Callouts for Healthcare Investing in Indial
India will have 1.2 billion people in the middleincome segment with over 42 per cent of the population in urban cities, by 2030. India’s healthcare and lifesciences market is estimated to reach 285 billion by 2028 implying a growth that is twice our GDP growth. These developments will lead to an estimated 30-35 billion in private capital investment getting allocated to the sector over the next 5 years.
4 min |
BioSpectrum Asia July 2024
BioSpectrum Asia
Oxford University designs computer simulations to guide future vaccine trials
University of Oxford scientists are launching new computer simulations that will model how we can strengthen the world’s response to some of the viruses most likely to cause the next pandemic.
1 min |
BioSpectrum Asia July 2024
BioSpectrum Asia
WHO and Italian National Institute of Health sign MoU to improve care for healthy ageing
The World Health Organization (WHO) and the Dementia Observatory (Osservatorio Demenze) have signed a threeyear Memorandum of Understanding (MoU) to formalise a close collaboration and exchange aimed at improving care for healthy ageing
1 min |
BioSpectrum Asia July 2024
BioSpectrum Asia
Noul participates in malaria project initiated by US CDC
On-device AI healthcare startup in South Korea, Noul has announced that it will jointly participate in a malaria diagnosis project initiated by US Centers for Disease Control and Prevention (CDC) with the Kenya Medical Research Institute (KEMRI).
1 min |
BioSpectrum Asia July 2024
BioSpectrum Asia
EnGeneIC, Singapore Institute of Advanced Medicine forge partnership to revolutionise cancer treatment in Asia
EnGeneIC, an Australiabased clinical-stage biopharmaceutical company pioneering the development of a First-in-Class targeted nano cell for cancer therapy, has announced strategic partnerships with Singapore Institute of Advanced Medicine Holdings (SAM) and Singapore Medical Incorporation (SMI).
1 min |
BioSpectrum Asia July 2024
BioSpectrum Asia
Singapore contributes S$24M to the WHO's inaugural investment round
At the World Health Organization’s (WHO) Strategic Roundtable on ‘All for Health, Health for All: the WHO Investment Case’ held in Geneva, Switzerland recently, Minister for Health Ong Ye Kung announced Singapore’s contribution of S$24 million to the WHO’s newly launched 2025/28 Investment Round.
1 min |
BioSpectrum Asia July 2024
BioSpectrum Asia
AbbVie inks deal worth $1.56B with China's FutureGen to develop IBD therapy
US-based firm AbbVie and FutureGen Biopharmaceutical (Beijing) have announced a license agreement to develop FG-M701, a next-generation TL1A antibody for the treatment of inflammatory bowel disease (IBD) currently in preclinical development.
1 min |
BioSpectrum Asia July 2024
BioSpectrum Asia
Shionogi signs €400M deal with French firm Cilcare to address hearing loss
Japan-based Shionogi & Co. has entered into an option agreement with French firm Cilcare DEV SAS to acquire the exclusive license for the development, manufacturing and commercialization of CIL001 and/or CIL003, the hearing loss treatment drug candidates worldwide.
1 min |
BioSpectrum Asia July 2024
BioSpectrum Asia
Singapore launches child & maternal health, well-being strategy and action plan report
The Interagency Child and Maternal Health & Well-being (CAMH) Taskforce in Singapore has completed its Strategy and Action Plan and published its report.
1 min |
BioSpectrum Asia July 2024
BioSpectrum Asia
SS Innovations' Mantra surgical robotic system receives approval for use in Indonesia
Indian firm SS Innovations International, Inc. (SSII), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, has announced that its SSi Mantra Surgical Robotic System has received regulatory approval from the Indonesian Ministry of Health for clinical use in the Republic of Indonesia.
1 min |
BioSpectrum Asia July 2024
BioSpectrum Asia
The Philippines- a preferred destination for medical education?
The Philippines is revolutionising medical education by providing affordable and value-formoney learning options at a fraction of the cost. With yearly tuition prices ranging from 2,000 to 6,000, it offers an economically realistic option for ambitious professionals worldwide. Furthermore, its curriculum is matched with US standards, ensuring seamless integration into foreign jobs, particularly in North America. This is supported by a strong network of residency programmes in the United States that aggressively seek the expertise of Philippine medical graduates.
4 min |